Panax quinquefolius whole

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Panax quinquefolius whole
DrugBank Accession Number
DB14296
Background

Panax quinquefolius whole is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

Type
Biotech
Groups
Experimental, Investigational
Synonyms
  • American Ginseng
  • American Ginseng Whole
  • Panax Quinquefolium Whole
  • Panax Quinquefolius
  • Sang Whole

Pharmacology

Indication

Not Available

Pharmacology
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Contraindications
Avoid life-threatening adverse drug events
Improve clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Adverseeffects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Products

Products2
Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
Mirapharm 22Capsule0.06 g/1OralMirapharm., Inc.2015-02-06Not applicableUS flag
SUPER MIRAPHARM (0.3g)Capsule0.0006 g/1OralMirapharm., Inc.2015-01-31Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Mirapharm 22Panax quinquefolius whole (0.06 g/1)CapsuleOralMirapharm., Inc.2015-02-06Not applicableUS flag
SUPER MIRAPHARM (0.3g)Panax quinquefolius whole (0.0006 g/1)CapsuleOralMirapharm., Inc.2015-01-31Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
8W75VCV53Q
CAS number
Not Available

References

General References
Not Available
RxNav
1428042

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
3CompletedSupportive CareChronic Myeloproliferative Disorders / Disorders, Lymphoproliferative / Fatigue / Leukemias / Malignant Lymphomas / Multiple Myeloma and Plasma Cell Neoplasm / Myelodysplastic Syndromes (MDS) / Myelodysplastic/Myeloproliferative Neoplasms / Precancerous Conditions / Unspecified Adult Solid Tumor, Protocol Specific1
3CompletedTreatmentHigh Blood Pressure (Hypertension)1
3CompletedTreatmentHyperglycemia1
2CompletedTreatmentAttention / Cognition / Learning / Memory / Wellbeing1
2CompletedTreatmentBreast Cancer1
2CompletedTreatmentHIV/AIDS-associated Fatigue1
2CompletedTreatmentMultiple Sclerosis1
1CompletedOtherHealthy Subjects (HS)1
0Active Not RecruitingSupportive CareCancer Survivors / Stage I Breast Cancer AJCC v7 / Stage I Colon Cancer AJCC v6 and v7 / Stage IA Breast Cancer AJCC v7 / Stage IB Breast Cancer AJCC v7 / Stage II Breast Cancer AJCC v6 and v7 / Stage II Colon Cancer AJCC v7 / Stage IIA Breast Cancer AJCC v6 and v7 / Stage IIA Colon Cancer AJCC v7 / Stage IIB Breast Cancer AJCC v6 and v7 / Stage IIB Colon Cancer AJCC v7 / Stage IIC Colon Cancer AJCC v7 / Stage III Breast Cancer AJCC V7 / Stage III Colon Cancer AJCC v7 / Stage IIIA Breast Cancer AJCC v7 / Stage IIIA Colon Cancer AJCC v7 / Stage IIIB Breast Cancer AJCC v7 / Stage IIIB Colon Cancer AJCC v7 / Stage IIIC Breast Cancer AJCC v7 / Stage IIIC Colon Cancer AJCC v71

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
CapsuleOral0.06 g/1
CapsuleOral0.0006 g/1
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Drug created on July 05, 2018 17:13 / Updated on June 12, 2020 16:53